Stem cells of the gastrointestinal tract, pancreas, liver and other columnar epithelia collectively resist cloning in their elemental states. Here we demonstrate the cloning and propagation of highly clonogenic, 'ground state' stem cells of the human intestine and colon. We show that derived stem-cell pedigrees sustain limited copy number and sequence variation despite extensive serial passaging and display exquisitely precise, cell-autonomous commitment to epithelial differentiation consistent with their origins along the intestinal tract. This developmentally patterned and epigenetically maintained commitment of stem cells is likely to enforce the functional specificity of the adult intestinal tract. Using clonally derived colonic epithelia, we show that toxins A or B of the enteric pathogen Clostridium difficile recapitulate the salient features of pseudomembranous colitis. The stability of the epigenetic commitment programs of these stem cells, coupled with their unlimited replicative expansion and maintained clonogenicity, suggests certain advantages for their use in disease modelling and regenerative medicine.
While dominating prospective strategies for regenerative medicine, embryonic stem cells and induced pluripotent stem cells (iPSCs) face formidable challenges including risk of teratoma, complex guiding protocols for lineage specificity, and limited regenerative capacity of the lineages ultimately produced [1] [2] [3] [4] [5] [6] [7] [8] . The success and promise of iPSCs have largely overshadowed efforts to harness stem cells intrinsic to regenerative tissues. Green and colleagues developed methods for cloning epidermal stem cells 9 that form a stratified epithelium upon engraftment, and these methods have been successfully applied to corneal, thymic and airway epithelia [10] [11] [12] . However, stem cells of columnar epithelial tissues resist cloning in a manner that maintains their immaturity during proliferative expansion, and instead must be carried forward as regenerative, differentiating 'organoids' [13] [14] [15] [16] [17] [18] . Despite their obvious potential in regenerative medicine and constant improvement 19 , the very low percentage of clonogenic cells in organoids limits the kinetics of their propagation as well as their utility for exploring the elemental stem cell.
The present study reports the cloning and propagation of 'ground state' human intestinal stem cells (ISC GS ). This technology offers insights into the molecular and functional features of columnar epithelial stem cells and their utility for disease modelling and regenerative medicine.
Cloning human fetal intestinal stem cells
We developed media (herein SCM-6F8) containing novel combinations of growth factors and regulators of TGF-b/BMP (transforming growth factor-b/bone morphogenetic protein), Wnt/b-catenin, EGF (epidermal growth factor), IGF (insulin-like growth factor) and Notch pathways 9, 20, 21 that supports the maintenance of human intestinal stem cells in a highly clonogenic, ground state form. Thus single-cell suspensions of intestinal epithelia derived from 20-to 21-week-old fetal demise cases yield colonies comprised of highly immature cells in which differentiation markers can be induced by Notch suppression (Fig. 1a ). Following induced differentiation via Wnt withdrawal, we were unable to recover ground state stem cells by our methods (Extended Data Fig. 1a-c) .
The clonogenicity of cells in the colonies was determined by singlecell transfer to be greater than 50% (Fig. 1b ). This high clonogenicity permits the rapid generation of single-cell 'pedigree' lines for expansion and characterization of lineage fates upon differentiation 12 (Fig. 1b ). Pedigree lines of ISC GS and tracheobronchial stem cells (TBSC GS ) 12 grown for several months in culture were differentiated in air-liquid interface (ALI) cultures for 10-30 days (Fig. 1c ). The ISC GS formed a highly uniform, 3D serpentine pattern, whereas TBSC GS produced a stratified epithelium with apically positioned ciliated and goblet cells. Histological sections of differentiated ISC GS revealed a columnar epithelium of villus-like structures marked by goblet (Muc2 1 ), endocrine (chromogranin A 1 ), and Paneth cells and polarized villin expression ( Fig. 1d ; Extended Data Fig. 1d ), indicating that the progeny of a single ISC GS can give rise to all epithelial lineages typically found in the small intestine. Importantly, differentiation of these ground state stem cells is accomplished by exposure to an ALI rather than a removal of factors such as Wnt that maintain immaturity.
While principal component analysis (PCA) of differentially expressed genes of ground state stem cells and ALI-differentiated tissue showed great divergence as expected for columnar and stratified epithelia, the gene expression profiles of undifferentiated ISC GS and TBSC GS differed by less than 4% (.2.0-fold, P , 0.05) ( Fig. 1e ). ISC GS showed high expression of intestinal stem-cell markers such as OLFM4, CD133 (ref. 22 ), Lgr5 (ref. 23 ) and Lrig1 (ref. 24) , whereas those from the airways had the typical stem cells markers of stratified epithelia (Krt14, Krt5 and Tp63 (ref. 11)) ( Fig. 1f ).
Intestinal stem cell variation
Approximately one in 2,000 cells from duodenum (I du SC), jejunum (I je SC) and ileum (I il SC) of a 21-week-old fetal intestine form a colony ( Fig. 2a ). Although these colonies were morphologically indistinguishable in culture, whole-genome expression analysis of multiple pedigrees showed a consistent, region-specific signature of 24-178 genes (.1.5-fold, P , 0.05; Fig. 2b ; Extended Data Fig. 2a ).
After 10 days at an ALI, I du SC and I je SC gave rise to a finer pattern of epithelial folds than that produced by I il SC (Fig. 2c ). By histology, villi appear progressively more robust along the anterior-posterior axis, with I il SC producing the larger villi and more numerous goblet cells ( Fig. 2d, e ). Interestingly, the epithelia derived from I du SC expressed markers more typical of gastric epithelium (for example, TFF2 and Muc5AC), consistent with duodenum's location between the stomach and the small intestine (Extended Data Fig. 2b ). I je SC-derived epithelium, however, expressed Muc2, consistent with intestinal epithelium (Extended Data Fig. 2c ), and I il SC produced an epithelium more akin to colon (Fig. 2f ). The pattern of proliferation in the ALI epithelia as measured by Ki67 staining was generally confined to cells proximal to the support membrane ( Fig. 2e , f). PCA mapping of gene expression revealed more divergence among ALIdifferentiated tissue than among the intestinal stem cells ( Fig. 2g ).
Colon stem cells
We also generated single-cell pedigree lines from the ascending, transverse, and descending colon from the same 21-week fetal demise case (Fig. 3a ). The variation in gene expression between the stem cells of these colonic segments was minimal with signatures of 19-28 genes (.1.5-fold, P , 0.05; Fig. 3b ). As with pedigrees derived from the intestinal epithelium, those from the colon could be propagated for months without loss of clonogenicity (not shown). Differentiation of these colon pedigrees under identical ALI conditions employed for the intestinal stem cells resulted in networks of 3D, large-diameter structures (Fig. 3c ). Consistently, the histology of these ALI cultures revealed patterns of broad intestinal glands dominated by goblet cells (Fig. 3d ). These ALI-generated tissues showed strong staining for intestinal goblet cell marker Muc2, as well as polarized villin and Krt20, typical of differentiated colonic epithelium ( Fig. 3e ). And while the colonic stem cells as a group showed minor differences in gene expression (see Figure 3b ), they gave rise to epithelia with more distinct gene expression profiles (Extended Data Fig. 3 ). PCA mapping of these expression data showed a clustering of the colon stem cells relative to the intestinal stem cells, with increasingly distant spaces occupied by stem cells of the ileum, jejunum and duodenum, respectively ( Fig. 3f ). This distinction in global gene expression patterns is reflected, for instance, in the differential expression of transcription factors. In particular, ONECUT2, NR0B2, TRPS1 and ZNF503 show relatively high expression in the small intestine stem cells, whereas those of the colon showed a bias for Hox genes as well as the global chromatin organizer genes SATB1 and SATB2 ( Fig. 3g , h).
Columnar versus stratified epithelia
The expression profiles of stem cells of human intestinal tract enabled a detailed comparison with those of stratified epithelia including human epidermis, corneal epithelium, mammary gland, prostate gland and upper airway. From this analysis it is clear that stratified epithelia, all of which depend on the p53-related stem-cell marker p63 for long-term self-renewal 11 , occupy a distinct expression space from that of the intestinal stem cells or other columnar epithelial stem cells ( Fig. 4a) . A survey of genes whose expression is associated with stem cells of one of these two major classes of epithelia revealed a strong bias for Olfm4, CD133 (ref. 22 LGR4 Ile   AC   TC   DC   TCL7L2  ERN2  GATA6  C11orf9  FOXP4  NFAT5  AHR  ONECUT2  NROB2  GATA4  ASCL2  SSX1  FOXA3  ID2  HNF4A  NOC2L  RASL11A  CDX2  ETV4  ZNF429  NEUROD1  MYC  NR1H4  BEX1  MLLT6  E2F4  ZNF384  HOXB8  HOXB6  HOXB9  HOXB7  PCBD1  ATOH1  SATB2  BHLHE41  TCEA3  HOXC10  ZNF587  HHEX  ZNF91  ZFP36L2 
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columnar epithelial stem cell markers as evidenced by their absence in fallopian tube stem cells, although Lrig1 is more highly expressed in fallopian tube stem cells than either those of the intestine or the colon (Extended Data Fig. 4a ). Notably, Bmi1, a member of the Polycomb group (PcG) PRC1-like complex implicated in self-renewal in both haematopoietic 26 and as reserve cells for proliferating, Lgr5 1 intestinal stem cells [27] [28] [29] , was not differentially expressed in the cloned intestinal versus stratified epithelial stem cells. And while many of the typical markers of intestinal stem cells such as Lgr5, CD44, Lrig1, EphB2 and ASCL2 show a decrease in expression as the intestinal stem cells are differentiated in ALI cultures, Bmi1 did not (Extended Data Fig. 4b, c ). These findings suggest that we are cloning either crypt cells or so-called '14' cells that have become crypt-like in their expression patterns. We also examined transcription factors differentially expressed in ISC compared to stratified epithelial stem cells in an effort to understand the regiospecificity of commitment programs of stem cells along the intestinal tract ( Fig. 4c ). In addition to six transcription factors that were uniformly highly expressed in stem cells of the intestinal tract (CREB3L1, Myb, NR5A2, IRF8, HNF4G and Msx2) versus tracheobronchial stem cells, this analysis revealed limited sets of transcription factors differentially expressed in stem cells along the anterior-posterior axis of the intestinal tract that conceivably function in maintaining commitment states. For instance, and consistent with previous observations 30 , GATA4 and GATA6 were expressed most strongly in the anterior portions of the intestinal tract ( Fig. 4c ). Significantly, the selective deletion of GATA4 and GATA6 in the murine duodenum and jejunum promotes ileal properties and a detrimental phenotype 30, 31 , suggesting a role for these transcription factors in maintaining segmental identity acting at the level of the stem cell. Similarly, the requirement for Onecut2 in the duodenum 32 might be at the level of the duodenal stem cells. It is likely that analyses of cloned stem cells from the various segments of the intestinal tract will help to unravel the roles of such segmentspecific transcription factors in the establishment of commitment and differentiation programs. Importantly, the overall properties of ISCs from fetal sources are conserved in those derived from endoscopic biopsies of paediatric and adult cases ( Fig. 4d-f ).
Genomic and lineage stability
Human embryonic stem cells and iPSC lines acquire with successive passages genomic structural variations, including some that confer a selective advantage 33, 34 . To assess the genomic stability of our ISC GS , we examined copy number (CNV) and single nucleotide variation (SNV) in two independent ISC GS pedigrees derived from the ileum of one fetal demise case after 50 (passage 5; P5), 100 (P10), 150 (P15), and 200 days (P20) of continuous proliferation (Fig. 5a, b) . At P5, when single ISC GS pedigrees can be amplified to an estimated 300 million to 75 billion cells, no chromosomal aneuploidies were detected, although one pedigree showed three interstitial deletions affecting two genes ( Fig. 5c ; Extended Data Fig. 5a ; Supplementary Information Table 1 ). This low level of structural variation was maintained though passage 10, although increased by P15 and at P20 one of the pedigrees showed a frank trisomy of chromosome 12 ( Fig. 5c ; Extended Data Fig. 5a ; Supplementary Information Table 1 ). A similar upward trend in CNV as a function of passage number was observed in five intestinal pedigrees (pedigrees 3-7) derived from a separate fetal demise case (Extended Data Figs 5, 6; Supplementary  Information Tables 1, 2) .
By exome sequencing, our original two pedigrees showed few (0-1) non-synonymous mutations through passage 10, and these increased modestly (1-2 new non-synonymous mutations) through P15 and P20 (Extended Data Fig. 5a ). None of these non-synonymous mutations have been reported as driver genes in human cancers. A similar trend was observed in the five pedigrees from the second fetal demise case followed through P5 and P25. By P25 the range of non-synonymous SNVs increased to 2-10 per clone, and while not involving obvious cancer driver genes, did include genes such as ECT2L and EP300 that might provide a selective growth advantage (Extended Data Fig. 5c ). These data indicate that most pedigrees sustain few genomic changes within the first 100 days of proliferative expansion. By P15 and through P25, however, half the pedigrees showed evidence for aneuploidy as well as an increase in interstitial CNV and SNVs with allele frequencies nearing 0.5, suggesting the rise of an advantaged subclone. We asked how these late-passage genomic changes might affect differentiation by comparing early and late passages of pedigree 2 in ALI differentiation. By all histological criteria, including Alcian blue staining for goblet cells and intestinal marker staining, we could not distinguish the ALI-differentiated epithelia derived from P7, P17 and P27 ( Fig. 5d ; Extended Data Fig. 7) . Similarly, we note that these intestinal stem cell pedigrees do not lose (or gain) clonogenicity when tested at P7 and P16, which remain stably above 50% (Fig. 5e, f) . Lastly, we found no evidence of tumorigenicity by these ground state intestinal stem cells, including those at P25 harbouring aneuploidies, following their subcutaneous implantation to immunodeficient (NOD.Cg-Prkdc scid Il2rg tm1Wjl /SzJ) mice 35 (Extended Data Fig. 8 ).
Modelling Clostridium difficile infections C. difficile is a Gram-positive, spore-forming bacterium and the primary cause of nosocomial diarrhoea and pseudomembranous colitis 36 . The pathogenicity of C. difficile is linked to its production of two similar, high molecular weight toxins TcdA and TcdB. While together TcdA and TcdB cause fluid secretion, inflammation, and colonic tissue damage, their respective and possible synergistic roles have been difficult to ascertain [37] [38] [39] . We therefore challenged colonic epithelia derived from cloned, ground state colonic stem cells with recombinant TcdB (Fig. 6a, b ; Extended Data Fig. 9a, b ). At higher concentrations or longer time points there is a loss of goblet cells, disruption of the crypt architecture, cell polarity, and a specific loss of tight versus adherens junction proteins that correlates with increased dextran permeability (Fig. 6c ). These dose-response changes in the ALI colonic epithelium mirror those of C. difficile-associated pseudomembranous colitis (Fig. 6d , Extended Data Fig. 9a, b ). Microarray analysis of ALI-generated colonic epithelia following nine TcdB treatment conditions revealed alterations in gene expression in a time-and dose-dependent manner (Fig. 6e, f ; Extended Data Fig. 9c-f ). Pathway analysis indicated that TcdB triggers changes in gene expression related to inflammation, RhoB-mediated actin regulation, and junctional dynamics previously implicated in C. difficile pathology 40, 41 . In addition, this analysis revealed that DUOX2 and DUOXA2 were consistently the two highest upregulated genes (Fig. 6e, f) . These proteins form an enzyme capable of producing hydrogen peroxide and have been implicated in the inflammation of inflammatory bowel disease (IBD) 42 . Finally, we also tested C. difficile TcdA in our model. TcdA is reported to be a specific enterotoxin 36, 37 , and indeed we found that it triggers similar cytopathic and permeability changes in ALI models of human colonic epithelium (Extended Data Fig. 10 ), albeit at lower doses than those effective for TcdB. Together these findings underscore the potential of this model system to recapitulate and elucidate C. difficile pathology.
Discussion
Adult stem cells of the highly regenerative intestinal tract remain largely defined by metabolic, marker profiling, or lineage tracing experiments in vivo or transplantation of cells from intestinal organoids 23, 43, 44 . As stem cells comprise only a minor component of organoids-perhaps less than 1% 45 -the molecular features of stem cells of columnar epithelia such as the intestinal tract have remained unclear. Therefore the selective cloning and proliferative expansion of highly clonogenic, ground state intestinal stem cells described here offers a first glimpse into the molecular properties of these cells. Our inability to convert differentiated cells to clonogenic cells supports the notion that we are cloning resident stem cells rather than somehow 'reprograming' differentiated enterocytes. These resident stem cells possess robust epigenetic programs of commitment to regiospecific intestinal differentiation that are stable despite more than six months of continuous propagation. This cellautonomous regiospecificity of stem cells along the intestinal tract argues against a unitary 'intestinal stem cell' or even one each for the histologically recognized segments, but rather a developmentally established spectrum of stem cells that ultimately maintains the histological and functional properties that define these segments. A heuristic deciphering of the commitment code from the regiospecific expression patterns presented here will guide parallel efforts with iPSCs to achieve appropriate lineage fates 46 . Interestingly, many inductive signalling pathways and transcription factors implicated in embryonic gut formation 47 may act to reinforce commitment codes via continued expression in stem cells of the intestinal tract. We anticipate that the ability to maintain these stem cells in their elemental state will enable the discovery of epigenetic mechanisms that underlie properties of very long-term self-renewal, exquisitely precise lineage commitment, and the intrinsically directed, selfassembly of differentiated epithelia. Although we demonstrate the potential of clonally-derived colonic epithelia to model the pathogenesis of C. difficile toxins, we anticipate the need to restore complexity 
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in the form of mesenchyme, immune cells, enteric neurons and perhaps components of the microbiome 48 to fully recapitulate disease dynamics. In particular, enteric maladies such as inflammatory bowel disease represent important medical challenges whose aetiologies most likely reside in interactions between the immune system, intestinal mucosa and intestinal flora 49, 50 . Finally, the ability to clone patient-specific, ground state stem cells from columnar epithelia via endoscopic biopsies, coupled with their orders-of-magnitude expansion kinetics over organoids, favours their use in regenerative medicine, pre-clinical trials and disease modelling.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper.
METHODS

In vitro culture of human small intestinal and colonic epithelial stem cells.
Intestinal tissue from 20-to 21-week-old late fetal demise cases were obtained under parent consent as de-identified material under approved institutional review board protocols at the Brigham and Women's Hospital, Boston, MA, USA (2009P002281). Terminal ileum endoscopic biopsies were obtained under informed consent and institutional review board approval at the Connecticut Children's Medical Center, Hartford, Connecticut USA (15-047J-2). Fetal intestinal tissue or 1 mm endoscopic biopsies from terminal ileum were collected into cold F12 media (Gibco, USA) with 5% fetal bovine serum (HyClone, USA) and then minced by sterile scalpel into 0.2-0.5 mm 3 sizes to a viscous and homogeneous appearance. The minced tissue was digested in 2 mg ml -1 collagenase type IV (Gibco, USA) at 37 uC for 30-60 min with agitation. Dissociated cells were passed through a 70-mm Nylon mesh (Falcon, USA) to remove aggregates and then were washed four times in cold F12 media, and then seeded onto a feeder layer of lethally irradiated 3T3-J2 cells 9, 12 in c-FAD media 9 modified to SCM-6F8 media by the addition of 125 ng ml -1 R-spondin1 (R&D systems, USA), 1 mM Jagged-1 (AnaSpec Inc., USA), 100 ng ml -1 human Noggin (Peprotech, USA), 2.5 mM Rock-inhibitor (Calbiochem, USA), 2 mM SB431542 (Cayman chemical, USA), and 10 mM nicotinamide (Sigma-Aldrich, USA). Cells were cultured at 37 uC in a 7.5% CO 2 incubator. The culture media was replaced every two days. Colonies were digested by 0.25% trypsin-EDTA solution (Gibco, USA) for 5-8 min and passaged every 7 to 10 days. To obtain single-cell suspensions colonies were trypsinized by TrypLE Express solution (Gibco, USA) for 8-15 min at 37 uC and cell suspensions were passed through 30-mm filters (Miltenyi Biotec, Germany). Approximately 20,000 epithelial cells were seeded to each well of 6-well plate. Cloning cylinder (Pyrex, USA) and high vacuum grease (Dow Corning, USA) were used to select single colonies for pedigrees. Gene expression analyses were performed on cells derived from passage 4-8 (P4-P8) cultures. Histology and immunostaining. Histology, haematoxylin and eosin (H&E), Alcian blue, periodic acid-Schiff (PAS), rhodamine B staining, immunohistochemistry, and immunofluorescence were performed using standard techniques. For immunofluorescence and immunohistochemistry, 4% paraformaldehydefixed, paraffin-embedded tissue sections were subjected to antigen retrieval in citrate buffer (pH 6.0, Sigma-Aldrich, USA) at 120 uC for 20 min, and a blocking procedure was performed with 5% bovine serum albumin (BSA, Sigma-Aldrich, USA) and 0.05% Triton X-100 (Sigma-Aldrich, USA) in phosphate-buffered saline (PBS; Gibco, USA) at room temperature for 1 h. Primary antibodies used in this study and staining condition were listed in Supplementary Information Table 3 . All images were captured by using the Inverted Eclipse Ti-Series (Nikon, Japan) microscope with Lumencor SOLA light engine and Andor Technology Clara Interline CCD camera and NIS-Elements Advanced Research v.4.13 software (Nikon, Japan) or LSM 780 confocal microscope (Carl Zeiss, Germany) with LSM software. Bright field cell culture images were obtained on an Eclipse TS100 microscope (Nikon, Japan) with Digital Sight DSFi1camera (Nikon, Japan) and NIS-Elements F3.0 software (Nikon, Japan). Stem cell differentiation. Air-liquid interface (ALI) culture of TBSCs was performed as described 12, 51 . Briefly, for ALI culture of intestinal and colonic epithelial stem cells, Transwell inserts (Corning, USA) were coated with 20% Matrigel (BD Biosciences, USA) and incubated at 37 uC for 30 min to polymerize. 200,000 irradiated 3T3-J2 cells were seeded to each transwell insert and incubated at 37 uC, 7.5% CO 2 incubator overnight. QuadroMACS Starting Kit (LS) (Miltenyi Biotec, Germany) was used to purify the stem cells by removal of feeder cells. 200,000-300,000 stem cells were seeded into each Transwell insert and cultured with SCM-6F8. At confluency (3-7 days), the apical media was removed through careful pipetting and the cultures were continued for an additional 6-12 days before analysis. Clostridium difficile toxin treatment and epithelial permeability assay. Clostridium difficile toxins A and B (TcdA, TcdB) were prepared as described 52 .
Intestinal stem cells were differentiated in air-liquid interface cultures as described above and treated with 100, 250, 500 pM and 10 nM TcdA or TcdB for 0, 8, 16, and 24 h). At these time points, membranes with differentiated epithelia were collected for histology and microarray analysis. 4 kDa FITC-dextran (Sigma-Aldrich, USA) was added to the apical chamber of the Transwell chambers for a final concentration of 0.5 mg ml -1 . Media was removed from the bottom compartment after different incubation times and fluorescence was read by fluorometer (Infinite M1000 PRO, excitation 490 nm, emission 520 nm, Tecan, USA). Implantation of intestinal stem cells. Intestinal stem cells (1.5 million cells) from different pedigrees with 50% of Matrigel (BD Bioscience, USA) were subcutaneously implanted into female, six-to eight-week-old immunodeficient (NOD.Cg-Prkdc scid Il2rg tm1Wjl /SzJ) mice 35 53 was performed for C. difficile toxin B treatment. For the region-specific gene signature of small intestine and colon comparison (PD, PJ and MI for Fig. 2b and AC, TC and DC for Fig. 3b) , differentially-expressed genes were selected with a cut-off value of 1.5-fold and P , 0.05 in each comparison (for example, (1) PD vs. PJ and (2) PD vs. MI) and then intersected genes in 2 gene lists of each comparison were taken as regiospecific gene sets. In the heat maps ( Fig. 2b and 3b ), 3 regiospecific gene sets (PD, PJ and MI, or AC, TC and DC) were combined, and the heat maps were made with Euclidean distance based on average linkage clustering. For C. difficile toxin B treatment data sets, samples from indicated time points and dosages were compared with control (untreated samples). Differentially-expressed genes (twofold upregulated and downregulated genes) were counted and plotted in 3D column plots (Extended Data Fig. 8c ). In comparison of 500 pM 24 h toxin B treatment with control, 39 genes were significantly upregulated (cut-off value: 3-fold and P , 0.05) and a heat map ( Fig. 6e) When running GATK, the minimum phred-scaled confidence threshold at which variants were called (-stand_call_conf) was 50, and the minimum phredscaled confidence threshold at which variants were emitted (-stand_emit_conf) is 30. The criteria of GATK Variant Filtration is as follows: --clusterWindowSize 10--filterExpression ''MQ0 . 4 && ((MQ0/(1.0*DP)) . 0.1)''--filterName ''HARD_ TO_VALIDATE''--filterExpression ''DP , 5''--filterName ''LowCoverage''--filterExpression ''QUAL , 30''--filterName ''VeryLowQual''--filterExpression ''QUAL . 30 && QUAL , 50''--filterName ''LowQual''--filterExpression ''QD , 1.5''--filterName ''LowQD''--filterExpression ''FS . 150''--filterName ''StrandBias''. Potential mouse genomic DNA contaminant reads were detected by alignment to the mouse genome (UCSC mm10) and those containing less than 3 mismatches were removed from further analysis. SNVs were called in each sample separately using SAMtools v0.1.19 57 and GATK in the exome capture targeted regions. Variants with at least Q50 confidence, phred-scaled quality score more than 40 and coverage higher than 10 were considered as true SNVs. Variants were annotated with ANNOVAR (version 11 Feb, 2013) 58 . Identical variant calls in intestinal stem cells (passage 5 and higher) when compared to passage 0 pooled samples were used to identify germline SNVs. Sanger sequencing validation was performed using primers designed with Primer3 software version 4.0 (http://frodo.wi.mit.edu/). Extracted genomic DNA was amplified with titanium Taq polymerase (Clontech Laboratories, CA, USA) and purified PCR products were sequenced in the forward directions using ABI PRISM BigDye Terminator Cycle Sequencing Ready Reaction kits and an ABI PRISM 3730 Genetic Analyzer (Applied Biosystems, CA, USA). We validated by PCR and Sanger sequencing 13 of 14 non-synonymous mutations called by our sequencing efforts suggesting a false discovery rate of less than 10%. Other quality control parameters are shown in Supplementary Information Table 4 . in ALI-generated colonic epithelia. a, Left, representative H&E images of ALI cultures at indicated times and concentration of TcdA exposure; right, immunofluorescence localization of adherens junction marker E-cadherin (ECAD; green) and mucin 2 (MUC2; red) in ALI-differentiated epithelia derived from transverse colon stem cells following incubation with 10 nM TcdA for the indicated durations. Scale bar, 100 mm; n 5 4 technical replicates. b, 3D plot of histological scoring of representative H&E time points and concentrations performed by a gastrointestinal pathologist according to a standard 0-3 rating for colonic epithelial integrity. c, Distribution of tight junction marker claudin 3 (Cldn3) and adherens junction marker (Cdh17) following treatment of ALI colonic epithelium with TcdA for the indicated times and doses. Scale bar, 50 mm; n 5 4 technical replicates. d, Histogram of permeability of ALI colonic epithelium (Papp) to small molecules (FD4, molecular mass 4,400 Da) following exposure to the indicated doses of TcdA for the indicated times.
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